Sugi Predict

Sugi Predict / Compounds / SCHEMBL17231435

SCHEMBL17231435

SCHEMBL17231435

CCCCCCCCCCCCOc1c(F)c(F)c(S(=O)(=O)ON2C(=O)c3cccc4c(CCCC)ccc(c34)C2=O)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ POLB P06746 3/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.36
▸ ELANE P08246 6/20 0.35
▸ KDM4E B2RXH2 7/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ HPGD P15428 5/20 0.34
▸ CTSG P08311 3/20 0.34
▸ HTT P42858 3/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ XBP1 P17861 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ TAF1 P21675 3/20 0.33
▸ BRD1 O95696 2/20 0.33
▸ BRPF1 P55201 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17146987 0.91 MAPT (0.38) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL17146986 0.91 MAPT (0.43) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL21389601 0.90 MAPT (0.39) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL17231430 0.86 MAPT (0.39) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL19999242 0.86 TDP1 (0.52) MAPTKMT2AMEN1POLBTDP1
SCHEMBL17231444 0.85 MAPT (0.39) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL19985723 0.82 TDP1 (0.42) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL13829208 0.80 MEN1 (0.33) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL17231441 0.79 TDP1 (0.40) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL17146964 0.78 ELANE (0.44) MAPTKMT2AMEN1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11754920-B2 Thermal acid generator and resist composition using same ADEKA CORPORATION (JP) 2023-09-12 — — US disclosed
US-20150315153-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, CATIONIC POLYMERIZATION INITIATOR, RESIST COMPOSITION, AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2015-11-05 — — US disclosed
US-20150315153-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, CATIONIC POLYMERIZATION INITIATOR, RESIST COMPOSITION, AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2015-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11754920-B2 Thermal acid generator and resist composition using same ACSL1, LRBA, GAR1 MAPT 4032/4885KMT2A 1839/4885MEN1 631/4885
US-20150315153-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, CATIONIC POLYMERIZATION INITIATOR, RESIST COMPOSITION, AND CATIONICALLY POLYMERIZABLE COMPOSITION ALAD, ARSA, AHR MAPT 4336/4885KMT2A 3617/4885MEN1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback